Stock listing
Integragen Sa
Selected listing: ALINT · EURONEXT · EUR · FR
Integragen Sa (Euronext:ALINT), Health Services. Latest release Jul 2, 2025: IntegraGen: Sales of €2.5 Million in the First Half of 2025 and Cash Position…
- Ticker
- Euronext:ALINT
- Asset type
- Stock
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- Euronext
- Currency
- EUR
About Integragen Sa
Integragen Sa is a public company listed on the Euronext Paris under the ticker ALINT. Integragen focuses on providing genomic analysis and bioinformatics services to advance research and healthcare solutions.
Latest news from Integragen Sa
IntegraGen: Sales of €2.5 Million in the First Half of 2025 and Cash Position of €2.1 Million
July 2, 2025
IntegraGen: 2024 Annual Results
April 29, 2025
IntegraGen: 2024 Revenues of €8.5m, Down 27% Compared With 2023 (+5% Excluding SeqOIA), and Cash Position of €1.9m
January 15, 2025
IntegraGen: 2024 Half-Year Results - Sales up 6% on a Like-for-Like Basis (Excluding SeqOIA) and Profitability Maintained
October 17, 2024
IntegraGen : reports €4.5m in revenues for H1 2024 representing 6% increase compared to H1 2023 and a cash position of €2.8m
July 24, 2024
Research Integragen Sa
Alternate listings
A1J1JV:LSX
DE · EUR
Alternate listing for Integragen Sa; the primary context on this page is ALINT:EURONEXT.
A1J1JV:LS
DE · EUR
Alternate listing for Integragen Sa; the primary context on this page is ALINT:EURONEXT.
ALINTP:TURQUOISE
GB · EUR
Alternate listing for Integragen Sa; the primary context on this page is ALINT:EURONEXT.
7N8:SWB
DE · EUR
Alternate listing for Integragen Sa; the primary context on this page is ALINT:EURONEXT.